Compare PRX to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 23.89 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 24.27 |
| Open: | 23.90 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 26.43 |
| Day's Range: | 23.49 - 24.15 |
|---|---|
| 52wk Range: | 8.57 - 24.60 |
| Volume: | 206,666 |
| Avg Vol (3m): | 500,392 |
| Market Cap: | 831.83M |
| P/E (ttm): | 21.39 |
| EPS (ttm): | 1.12 |
| Div & Yield: | N/A (N/A) |
| Wed, Nov 25 | Build Your Fortune With These Winnersat Motley Fool |
| Wed, Nov 25 | Par Pharma buys back $30.8M in senior notesAP |
| Wed, Nov 25 | Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender OfferPR Newswire |
| Fri, Nov 20 | Drugmaker Par Shapes A Base But Needs TimeInvestor's Business Daily |
| Mon, Nov 16 | Par Pharmaceutical to Host Analyst Day on December 3rdPR Newswire |
| Mon, Nov 16 | Par Pharma gets FDA approval for generic Ultram ERAP |
| Mon, Nov 16 | UPDATE - Par Pharma gets FDA nod for generic version of Ultramat Reuters |
| Mon, Nov 16 | Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ERPR Newswire |
| Fri, Nov 13 | PAR PHARMACEUTICAL COMPANIES, INC. FinancialsEDGAR Online Financials |
| Fri, Nov 13 | [$$] Biotech Stock Mailbag: Cardium Therapeuticsat RealMoney by TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.